BioPharma Resources

Drug Trial Radar · NCT07185009

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 751 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

751

Planned (sponsor's estimate)

Start

Jan 16, 2026

Primary completion

Sep 21, 2028

Study completion Apr 28, 2033

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
Collaborators
Teva Branded Pharmaceutical Products R&D LLC
First posted
Sep 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 16 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 286 weeks including: * 40-week Pivotal Maintenance Sub-Study * 240-week Open-Label Extension (OLE) Sub-Study * 45-day Follow-up Visit Note: For the participants who do not enroll into OLE Sub-Study, the duration will be up to 46 weeks, including the 40-week maintenance period and a 45-day follow-up visit. The treatment duration may be up to 280 weeks including: * 40 weeks in Pivotal Maintenance Sub-Study * 240 weeks in OLE Sub-Study The total number of on-site visit will be up to 32: * 21 visits in the Pivotal Maintenance Sub-Study. * 11 visits in the OLE Sub-Study.

Conditions

  • Ulcerative Colitis

Interventions

  • DuvakitugDrug

    Pharmaceutical form: Injection solution Route of administration: SC injection

  • PlaceboDrug

    Pharmaceutical form:Injection solution-Route of administration:SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants achieving clinical remission by modified Mayo Score (mMS).Time frame: Week 40

Locations

171 sites in 31 countries. Site status is shown where the registry gives one.

  • Del Sol Research Management, LLC - Site Number: 8400012

    Tucson, Arizona · Recruiting

  • Southern California GI & Liver Centers - Site Number: 8400062

    Coronado, California · Recruiting

  • United Medical Doctors CA - Site Number: 8400044

    Murrieta, California · Recruiting

  • Om Research, LLC - Victorville - Site Number: 8400022

    Victorville, California · Recruiting

  • Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039

    Colorado Springs, Colorado · Recruiting

  • Clinical Research of Osceola - Site Number: 8400013

    Kissimmee, Florida · Recruiting

  • Bioresearch Partner-Kendale Lakes - Site Number: 8400053

    Miami, Florida · Recruiting

  • NMC Research LLC - Site Number: 8400033

    Tampa, Florida · Recruiting

  • Atlanta Gastroenterology Associates-Site Number: 8400109

    Atlanta, Georgia · Recruiting

  • Grand Teton Research Group, PLLC-Site Number: 8400127

    Idaho Falls, Idaho · Recruiting

  • GI Alliance - Gurnee-Site Number:

    Gurnee, Illinois · Recruiting

  • Gastroenterology Health Partners, PLLC - New Albany - Site Number: 8400100

    New Albany, Indiana · Recruiting

  • University of Kentucky Hospital/UK Albert B. Chandler Hospital-Site Number: 8400058

    Lexington, Kentucky · Recruiting

  • GI Alliance - Baton Rouge - Site Number: 8400129

    Baton Rouge, Louisiana · Recruiting

  • Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville - Site Number: 8400128

    Mandeville, Louisiana · Recruiting

  • Delta Research Partners - Site Number: 8400087

    Monroe, Louisiana · Recruiting

  • UMass Memorial Medical Center-Site Number: 8400121

    Worcester, Massachusetts · Recruiting

  • Gastroenterology Associates of Western Michigan - Site Number: 8400060

    Wyoming, Michigan · Recruiting

  • Gateway Gastroenterology - Site Number: 8400097

    Chesterfield, Missouri · Recruiting

  • BVL Clinical Research - Site Number: 8400005

    Liberty, Missouri · Recruiting

  • Premier Health Research, LLC-Site Number: 8400114

    Sparta, New Jersey · Recruiting

  • MedTraits NY - Site Number: 8400045

    Maspeth, New York · Recruiting

  • NYU Langone Health-Site Number: 8400091

    New York, New York · Recruiting

  • Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040

    New York, New York · Recruiting

  • Lenox Hill Hospital-Site Number: 8400052

    New York, New York · Recruiting

  • New York Gastroenterology Associates - Site Number: 8400009

    New York, New York · Recruiting

  • Cross Creek Medical Clinic - Site Number: 8400057

    Fayetteville, North Carolina · Recruiting

  • Ohio Gastroenterology Group Inc. - Site Number: 8400006

    Columbus, Ohio · Recruiting

  • North Shore Gastroenterology Research - Site Number: 8400130

    Westlake, Ohio · Recruiting

  • The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107

    Pittsburgh, Pennsylvania · Recruiting

  • University Gastroenterology-Site Number: 8400103

    Providence, Rhode Island · Recruiting

  • One of a Kind Clinical Research Center TX, LLC-Site Number: 8400125

    Kingwood, Texas · Recruiting

  • GI Alliance - Lubbock - Site Number: 8400092

    Lubbock, Texas · Recruiting

  • Gastroenterology Research of San Antonio LLC - Site Number: 8400054

    San Antonio, Texas · Recruiting

  • Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101

    Southlake, Texas · Recruiting

  • Tyler Research Institute, LLC - Site Number: 8400095

    Tyler, Texas · Recruiting

  • The Vancouver Clinic Inc. P.S. - Site Number: 8400090

    Vancouver, Washington · Recruiting

  • Investigational Site Number : 0320007

    Rosario, Santa Fe Province, Argentina · Recruiting

  • Investigational Site Number : 0360001

    South Brisbane, Australia · Recruiting

  • Investigational Site Number : 0400002

    Salzburg, Austria · Recruiting

Showing 40 of 171 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.